Novartis has received a positive opinion recommending European Union approval of Galvus (vildagliptin) as a new once-daily oral medication for type 2 diabetes, a disease affecting an estimated 28 million patients in Europe.
Read More...
[Source: Yahoo! News Search Results for Diabetes]
Why this Blog?
Shortly after my 12 year old nephew was diagnosed with Diabetes 1, I started this blog for he and his mother. There is so much to learn and so much to know and so many unanswered questions. My hope is that it provides a place for knowledge and healing. To your health nephew!
Love Always-
Hannah
Love Always-
Hannah
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment